Accounting for 46% of all exports, the EU was the Swiss pharmaceutical industry's biggest trading partner in 2019.
is the direct contribution of the pharmaceutical sector to the gross domestic product (GDP), making it one of Switzerland's most significant private-industry sectors.
People in Switzerland benefit from access to high-quality healthcare provision. However, there is still a need for action and improvement in various areas.
Our mission is to ensure that patients in Switzerland receive access to innovative medicines and therapies as quickly as possible.
show more articles
Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.
Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.
Information on our key figures and activities in the financial year 2022
read more
Introducing Interpharma
read more
More about the tasks and overriding aims of Interpharma
read more
Contact us
read more
Latest information and media contacts for media representatives
read more
Download